Hokkaido

News Highlights

“Creapea M&A,” a business succession and M&A support service for small and medium-sized enterprises based in Hokkaido, has been launched. The service addresses specific schemes unique to medical institutions (such as transfer of equity interests, changes in corporate representatives, and refund of funds), provides appropriate business valuation considering complex factors like medical practice profits, fixed assets, licenses, staff, and patient base, and offers ongoing support for stabilizing the new system after the transaction.

M&A Medical Editorial Department’s Perspective

The launch of “Creapea M&A” from Hokkaido suggests a trend of community-based support for SMEs extending into the healthcare sector. Particularly in medical institution M&A, evaluating intangible assets is crucial, going beyond mere financial statement assessments. This includes the continuity of medical services following a doctor’s retirement or replacement, the transfer of various licenses, and, most importantly, the contribution to regional healthcare. The fact that Creapea M&A is branded for “small businesses” holds the potential to offer concrete business succession options for the owners of clinics and small hospitals that form the backbone of local communities, which have often been difficult to access through large M&A boutiques or professional firms. From the perspective of maintaining and developing regional healthcare, the expansion of such local support systems is a welcome development.

Points Highlighted by This News

• The spread of M&A support for SMEs rooted in the Hokkaido region to medical institutions.
• Emphasis on the evaluation of hard-to-quantify assets unique to medical institutions, such as “licenses” and “patient base.”
• The potential for opening doors to clinics and similar entities, previously not considered M&A targets, by explicitly stating “for small businesses.”
• An approach to ensure the continuity of medical quality and community contribution post-business succession by including “ongoing support” after the transaction.

Practical Questions Arising from This News

• What specific medical institution schemes (transfer of equity interests, changes in corporate representatives, refund of funds, etc.) can Creapea M&A handle?
• Are there similar M&A support services specializing in small medical institutions in regions outside of Hokkaido?
• In “appropriate business valuation,” how are factors other than medical practice profits (such as staff and patient base) quantified and evaluated?

If You Feel “Should I Consult?”

If your clinic is located in Hokkaido and you are concerned about a lack of successors or business continuity, “Creapea M&A” could be a strong option. This is especially true for those who previously thought M&A was only for large-scale medical institutions, or for those who wish to maintain the healthcare provision system in their region. It is worth consulting with them at least once. You can expect meticulous support from experts who understand the local situation. We recommend checking the service details first for information gathering.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, providing full support for the business succession of medical corporations, hospitals, and clinics on a success fee basis. Consultations are handled with strict confidentiality. Free consultations here.